GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA
Delisted
GRNA was delisted on the 21st of July, 2023.
57 hedge funds and large institutions have $86.2M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+7
Holders Change %
+14%
% of All Funds
0.99%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
31
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$23.8M |
| 2 |
Baird Financial Group
Milwaukee,
Wisconsin
|
$6.63M |
| 3 |
BlackRock
New York
|
$8.77M |
| 4 |
CGC
Continental Grain Company
New York
|
$15.1M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
$2.56M |
Top Sellers
| 1 |
VS
VK Services
Menlo Park,
California
|
$0 |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
$5.15M |
| 3 |
Squarepoint
New York
|
$0 |
| 4 |
HF
HRT Financial
New York
|
$0 |
| 5 |
Two Sigma Investments
New York
|
$0 |
